Quick Answer
OS Therapies Inc reported Common Stock Shares Outstanding of 37.11 million shares for the year ending 2025.
- OS Therapies Inc showed an increase of +77.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from OS Therapies Inc's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2024: 11.98 million shares | Q2 2024: 5.99 million shares | Q3 2024: 21.18 million shares | Q1 2025: 21.35 million shares | Q2 2025: 29.66 million shares | Q3 2025: 33.27 million shares.
- Over the full 3 years of available data (2023 to 2025), OS Therapies Inc's Common Stock Shares Outstanding has grown by 595.0%.
- Historical annual values: Fiscal year 2025: 37.11 million shares | Fiscal year 2024: 20.87 million shares | Fiscal year 2023: 5.34 million shares.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: